2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q2 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,507,200 | -49.6% | 1,660,000 | +30.0% | 0.02% | -50.0% |
| Q2 2023 | $12,922,754 | +499.7% | 1,276,952 | +504.4% | 0.04% | +442.9% |
| Q1 2023 | $2,155,046 | -18.3% | 211,279 | -25.0% | 0.01% | -22.2% |
| Q4 2022 | $2,639,061 | +14.5% | 281,650 | +77.8% | 0.01% | 0.0% |
| Q3 2022 | $2,305,000 | -26.7% | 158,450 | -33.5% | 0.01% | -30.8% |
| Q2 2022 | $3,146,000 | -40.7% | 238,300 | -23.3% | 0.01% | -38.1% |
| Q1 2022 | $5,301,000 | -64.7% | 310,700 | -47.0% | 0.02% | -65.0% |
| Q4 2021 | $15,037,000 | – | 586,707 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
| Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
| Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
| EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
| Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
| Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
| CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
| Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |